The Acetyl Code in Rheumatoid Arthritis and Other Rheumatic Diseases

References

• Smolen JS , AletahaD , McinnesIB . Rheumatoid arthritis . Lancet388 ( 10055 ), 2023 – 2038 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• De Hair MJ , LandeweRB , Van De SandeMGet al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis . Ann. Rheum. Dis.72 ( 10 ), 1654 – 1658 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium , MallerJB , McveanGet al.Bayesian refinement of association signals for 14 loci in 3 common diseases . Nat. Genet.44 ( 12 ), 1294 – 1301 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ross KA . Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn’s disease, coronary artery disease, hypertension, rheumatoid arthritis, Type-1 diabetes, and Type-2 diabetes . BMC Med.9 , 12 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kyburz D , KarouzakisE , OspeltC . Epigenetic changes: the missing link . Best Pract. Res. Clin. Rheumatol.28 ( 4 ), 577 – 587 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , ReedquistKA . The ascent of acetylation in the epigenetics of rheumatoid arthritis . Nat. Rev. Rheumatol.9 ( 5 ), 311 – 318 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sohn C , LeeA , QiaoY , LoupasakisK , IvashkivLB , KallioliasGD . Prolonged tumor necrosis factor alpha primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin . Arthritis Rheumatol.67 ( 1 ), 86 – 95 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Bottini N , FiresteinGS . Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors . Nat. Rev. Rheumatol.9 ( 1 ), 24 – 33 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Strahl BD , AllisCD . The language of covalent histone modifications . Nature403 ( 6765 ), 41 – 45 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Tessarz P , KouzaridesT . Histone core modifications regulating nucleosome structure and dynamics . Nat. Rev. Mol. Cell Biol.15 ( 11 ), 703 – 708 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Calo E , WysockaJ . Modification of enhancer chromatin: what, how, and why?Mol. Cell49 ( 5 ), 825 – 837 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hu N , QiuX , LuoYet al. Abnormal histone modification patterns in lupus CD4+ T cells . J. Rheumatol.35 ( 5 ), 804 – 810 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Garcia BA , BusbySA , ShabanowitzJ , HuntDF , MishraN . Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition . J. Proteome Res.4 ( 6 ), 2032 – 2042 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , YangY , LuoYet al. Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis . Clin. Immunol.149 ( 1 ), 46 – 54 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Angiolilli C , GrabiecAM , FergusonBSet al. Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression . Ann. Rheum. Dis.75 ( 2 ), 430 – 438 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wada TT , ArakiY , SatoKet al. Aberrant histone acetylation contributes to elevated interleukin-6 production in rheumatoid arthritis synovial fibroblasts . Biochem. Biophys. Res. Commun.444 ( 4 ), 682 – 686 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maciejewska-Rodrigues H , KarouzakisE , StrietholtSet al. Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression . J. Autoimmun.35 ( 1 ), 15 – 22 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Farrajota K , ChengS , Martel-PelletierJet al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism . Arthritis Rheum.52 ( 1 ), 94 – 104 ( 2005 ).
   PubMedGoogle Scholar
• Zhou Y , QiuX , LuoYet al. Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells . Lupus20 ( 13 ), 1365 – 1371 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Oelke K , LuQ , RichardsonDet al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors . Arthritis Rheum.50 ( 6 ), 1850 – 1860 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zhang Z , SongL , MaurerK , PetriMA , SullivanKE . Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes . Genes Immun.11 ( 2 ), 124 – 133 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , FanPS , KahalehB . Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts . Arthritis Rheum.54 ( 7 ), 2271 – 2279 ( 2006 ).
   PubMedGoogle Scholar
• Marmorstein R , ZhouMM . Writers and readers of histone acetylation: structure, mechanism, and inhibition . Cold Spring Harb. Perspect. Biol.6 ( 7 ), a018762 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P , KnappS . Targeting bromodomains: epigenetic readers of lysine acetylation . Nat. Rev. Drug Discov.13 ( 5 ), 337 – 356 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gillespie J , SavicS , WongCet al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients . Arthritis Rheum.64 ( 2 ), 418 – 422 ( 2012 ).
   PubMedGoogle Scholar
• Ghosh AK , BhattacharyyaS , LafyatisRet al. p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta: epigenetic feed-forward amplification of fibrosis . J. Invest. Dermatol.133 ( 5 ), 1302 – 1310 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hawtree S , MuthanaM , WilkinsonJM , AkilM , WilsonAG . Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis . Hum. Mol. Genet.24 ( 19 ), 5367 – 5377 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kawabata T , NishidaK , TakasugiKet al. Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis . Arthritis Res. Ther.12 ( 4 ), R133 ( 2010 ).
   PubMedGoogle Scholar
• Nawrocki MJ , StrugalaAJ , PiotrowskiP , WudarskiM , OlesinskaM , JagodzinskiPP . JHDM1D and HDAC1–3 mRNA expression levels in peripheral blood mononuclear cells of patients with systemic lupus erythematosus . Z. Rheumatol.74 ( 10 ), 902 – 910 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Horiuchi M , MorinobuA , ChinT , SakaiY , KurosakaM , KumagaiS . Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts . J. Rheumatol.36 ( 8 ), 1580 – 1589 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Angiolilli C , KabalaPA , GrabiecAMet al. Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes . Ann. Rheum. Dis. doi:10.1136/annrheumdis-2015-209064 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Kelly RD , CowleySM . The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts . Biochem. Soc. Trans.41 ( 3 ), 741 – 749 ( 2013 ).
   PubMedGoogle Scholar
• Dou C , LiN , DingNet al. HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis . Am. J. Physiol. Cell Physiol.310 ( 10 ), C780 – C787 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Chen X , BarozziI , TermaniniAet al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages . Proc. Natl Acad. Sci. USA109 ( 42 ), E2865 – E2874 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mullican SE , GaddisCA , AlenghatTet al. Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation . Genes Dev.25 ( 23 ), 2480 – 2488 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Haberland M , MontgomeryRL , OlsonEN . The many roles of histone deacetylases in development and physiology: implications for disease and therapy . Nat. Rev. Genet.10 ( 1 ), 32 – 42 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ha CH , WangW , JhunBSet al. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis . J. Biol. Chem.283 ( 21 ), 14590 – 14599 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Grozinger CM , SchreiberSL . Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14–3–3-dependent cellular localization . Proc. Natl Acad. Sci. USA97 ( 14 ), 7835 – 7840 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Cao K , WeiL , ZhangZet al. Decreased histone deacetylase 4 is associated with human osteoarthritis cartilage degeneration by releasing histone deacetylase 4 inhibition of runt-related transcription factor-2 and increasing osteoarthritis-related genes: a novel mechanism of human osteoarthritis cartilage degeneration . Arthritis Res. Ther.16 ( 6 ), 491 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lu J , SunY , GeQ , TengH , JiangQ . Histone deacetylase 4 alters cartilage homeostasis in human osteoarthritis . BMC Musculoskelet. Disord.15 , 438 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jeffries MA , DonicaM , BakerLWet al. Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic subchondral bone and similarity to overlying cartilage . Arthritis Rheumatol.68 ( 6 ), 1403 – 1414 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bradley EW , CarpioLR , OlsonEN , WestendorfJJ . Histone deacetylase 7 (Hdac7) suppresses chondrocyte proliferation and beta-catenin activity during endochondral ossification . J. Biol. Chem.290 ( 1 ), 118 – 126 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yan K , CaoQ , ReillyCM , YoungNL , GarciaBA , MishraN . Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity . J. Biol. Chem.286 ( 33 ), 28833 – 28843 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Beier UH , WangL , HanR , AkimovaT , LiuY , HancockWW . Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms . Sci. Signal.5 ( 229 ), ra45 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wang B , RaoYH , InoueMet al. Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production . Nat. Commun.5 , 3479 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dvir-Ginzberg M , MobasheriA , KumarA . The role of sirtuins in cartilage homeostasis and osteoarthritis . Curr. Rheumatol. Rep.18 ( 7 ), 43 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Niederer F , OspeltC , BrentanoFet al. SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance . Ann. Rheum. Dis.70 ( 10 ), 1866 – 1873 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wendling D , AbbasW , Godfrin-ValnetMet al. Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis . PLoS ONE10 ( 3 ), e0119981 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Woo SJ , LeeSM , LimHSet al. Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation . Exp. Mol. Med.48 , e221 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Park SY , LeeSW , KimHYet al. SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis . J. Mol. Med. (Berl.)94 ( 8 ), 921 – 931 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Zerr P , Palumbo-ZerrK , HuangJet al. Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis . Ann. Rheum. Dis.75 ( 1 ), 226 – 233 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Lin J , SunB , JiangC , HongH , ZhengY . Sirt2 suppresses inflammatory responses in collagen-induced arthritis . Biochem. Biophys. Res. Commun.441 ( 4 ), 897 – 903 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Klein K , KabalaPA , GrabiecAMet al. The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts . Ann. Rheum. Dis.75 ( 2 ), 422 – 429 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Knevel R , KleinK , SomersKet al. Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis . Ann. Rheum. Dis.73 ( 11 ), 2038 – 2046 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Choudhary C , KumarC , GnadFet al. Lysine acetylation targets protein complexes and co-regulates major cellular functions . Science325 ( 5942 ), 834 – 840 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Bae S , KimH , LeeNet al. α-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis . J. Immunol.189 ( 1 ), 365 – 372 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fan SS , ZongM , ZhangH , LuY , LuTB , FanLY . Decreased expression of alpha-enolase inhibits the proliferation of hypoxia-induced rheumatoid arthritis fibroblasts-like synoviocytes . Mod. Rheumatol.25 ( 5 ), 701 – 707 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Arito M , NagaiK , OokaSet al. Altered acetylation of proteins in patients with rheumatoid arthritis revealed by acetyl-proteomics . Clin. Exp. Rheumatol.33 ( 6 ), 877 – 886 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kok SH , LinLD , HouKLet al. Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling . Arthritis Rheum.65 ( 3 ), 639 – 649 ( 2013 ).
   PubMedGoogle Scholar
• Klampfer L , HuangJ , SwabyLA , AugenlichtL . Requirement of histone deacetylase activity for signaling by STAT1 . J. Biol. Chem.279 ( 29 ), 30358 – 30368 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Jeong Y , DuR , ZhuXet al. Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1 . J. Leukoc. Biol.95 ( 4 ), 651 – 659 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fu Y , KinterM , HudsonJet al. Aging promotes sirtuin 3-dependent cartilage superoxide dismutase 2 acetylation and osteoarthritis . Arthritis Rheumatol.68 ( 8 ), 1887 – 1898 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Nakazawa M , ArataniS , HattaMet al. TNFalpha induces acetylation of p53 but attenuates its transcriptional activation in rheumatoid synoviocytes . Int. J. Mol. Med.10 ( 3 ), 269 – 275 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Reed SM , QuelleDE . p53 Acetylation: regulation and consequences . Cancers (Basel)7 ( 1 ), 30 – 69 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mack GS . To selectivity and beyond . Nat. Biotechnol.28 ( 12 ), 1259 – 1266 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Adcock IM . HDAC inhibitors as anti-inflammatory agents . Br. J. Pharmacol.150 ( 7 ), 829 – 831 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Mishra N , ReillyCM , BrownDR , RuizP , GilkesonGS . Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse . J. Clin. Invest.111 ( 4 ), 539 – 552 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Chung YL , LeeMY , WangAJ , YaoLF . A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis . Mol. Ther.8 ( 5 ), 707 – 717 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Zwergel C , ValenteS , JacobC , MaiA . Emerging approaches for histone deacetylase inhibitor drug discovery . Expert Opin. Drug Discov.10 ( 6 ), 599 – 613 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Grabiec AM , KorchynskyiO , TakPP , ReedquistKA . Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay . Ann. Rheum. Dis.71 ( 3 ), 424 – 431 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Nishida K , KomiyamaT , MiyazawaSet al. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression . Arthritis Rheum.50 ( 10 ), 3365 – 3376 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Reilly CM , MishraN , MillerJMet al. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid . J. Immunol.173 ( 6 ), 4171 – 4178 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lin HS , HuCY , ChanHYet al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents . Br. J. Pharmacol.150 ( 7 ), 862 – 872 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Lohman RJ , IyerA , FairlieTJet al. Differential anti-inflammatory activity of HDAC inhibitors in human macrophages and rat arthritis . J. Pharmacol. Exp. Ther.356 ( 2 ), 387 – 396 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Vojinovic J , DamjanovN , D’urzoCet al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis . Arthritis Rheum.63 ( 5 ), 1452 – 1458 ( 2011 ).
   PubMedGoogle Scholar
• Regna NL , ChafinCB , HammondSE , PuthiyaveetilAG , CaudellDL , ReillyCM . Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo . Clin. Immunol.151 ( 1 ), 29 – 42 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mele DA , SalmeronA , GhoshS , HuangHR , BryantBM , LoraJM . BET bromodomain inhibition suppresses TH17-mediated pathology . J. Exp. Med.210 ( 11 ), 2181 – 2190 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wei S , SunY , ShaH . Therapeutic targeting of BET protein BRD4 delays murine lupus . Int. Immunopharmacol.29 ( 2 ), 314 – 319 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Xiao Y , LiangL , HuangMet al. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes . Rheumatology (Oxford)55 ( 1 ), 173 – 184 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Balasubramanian S , RamosJ , LuoW , SirisawadM , VernerE , BuggyJJ . A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas . Leukemia22 ( 5 ), 1026 – 1034 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Li S , FossatiG , MarchettiCet al. Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo . J. Biol. Chem.290 ( 4 ), 2368 – 2378 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Jochems J , BouldenJ , LeeBGet al. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability . Neuropsychopharmacology39 ( 2 ), 389 – 400 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Van Den Bossche J , NeeleAE , HoeksemaMAet al. Inhibiting epigenetic enzymes to improve atherogenic macrophage functions . Biochem. Biophys. Res. Commun.455 ( 3–4 ), 396 – 402 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cantley MD , FairlieDP , BartoldPM , MarinoV , GuptaPK , HaynesDR . Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis . Rheumatology54 ( 9 ), 1713 – 1723 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cleophas MC , CrisanTO , LemmersHet al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases . Ann. Rheum. Dis.75 ( 3 ), 593 – 600 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Hsieh IN , LiouJP , LeeHY , LaiMJ , LiYH , YangCR . Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009 . Cell Death Dis.5 , e1166 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Matalon S , PalmerBE , NoldMFet al. The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro . J. Acquir. Immune Defic. Syndr.54 ( 1 ), 1 – 9 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Fass DM , ShahR , GhoshBet al. Effect of inhibiting histone deacetylase with short-chain carboxylic acids and their hydroxamic acid analogs on vertebrate development and neuronal chromatin . ACS Med. Chem. Lett.2 ( 1 ), 39 – 42 ( 2010 ).
   PubMedGoogle Scholar
• Yao Y , TuZ , LiaoCet al. Discovery of novel class i histone deacetylase inhibitors with promising in vitro and in vivo antitumor activities . J. Med. Chem.58 ( 19 ), 7672 – 7680 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Furumai R , MatsuyamaA , KobashiNet al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases . Cancer Res.62 ( 17 ), 4916 – 4921 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Grigg RE , InmanM , PackhamG . N-(2-aminophenyl) benzamide derivatives as histone deacetylase inhibitors . Patent number EP2729450A1 ( 2014 ).
   Google Scholar
• Scholz C , WeinertBT , WagnerSAet al. Acetylation site specificities of lysine deacetylase inhibitors in human cells . Nat. Biotechnol.33 ( 4 ), 415 – 423 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Vishwakarma S , IyerLR , MuleyMet al. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects . Int. Immunopharmacol.16 ( 1 ), 72 – 78 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee J , HongEC , JeongHet al. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model . Int. J. Rheum. Dis.18 ( 5 ), 514 – 523 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Joosten LA , LeoniF , MeghjiS , MascagniP . Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis . Mol. Med.17 ( 5–6 ), 391 – 396 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Regna NL , ViesonMD , LuoXMet al. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice . Clin. Immunol.162 , 58 – 73 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Lobera M , MadaussKP , PohlhausDTet al. Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group . Nat. Chem. Biol.9 ( 5 ), 319 – 325 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Xuzhu G , Komai-KomaM , LeungBPet al. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function . Ann. Rheum. Dis.71 ( 1 ), 129 – 135 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wei J , GhoshAK , ChuHet al. The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling . Arthritis Rheumatol.67 ( 5 ), 1323 – 1334 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Plant D , WebsterA , NairNet al. Differential methylation as a biomarker of response to etanercept in patients with rheumatoid arthritis . Arthritis Rheumatol.68 ( 6 ), 1353 – 1360 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Ai R , WhitakerJW , BoyleDLet al. DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis . Arthritis Rheumatol.67 ( 7 ), 1978 – 1980 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ma F , ZhangCY . Histone modifying enzymes: novel disease biomarkers and assay development . Expert Rev. Mol. Diagn.16 ( 3 ), 297 – 306 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Keung AJ , JoungJK , KhalilAS , CollinsJJ . Chromatin regulation at the frontier of synthetic biology . Nat. Rev. Genet.16 ( 3 ), 159 – 171 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Shakespear MR , HaliliMA , IrvineKM , FairlieDP , SweetMJ . Histone deacetylases as regulators of inflammation and immunity . Trends Immunol.32 ( 7 ), 335 – 343 ( 2011 ).
   PubMed Web of Science ®Google Scholar